Rituximab
rrPTCL-R-PD1-001
Unknown small_molecule active
Quick answer
Rituximab for Peripheral T-Cell Lymphoma, Not Otherwise Specified is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active